ClinicalTrials.gov
public full text
Public Domain
A Clinical Trial of Fluvoxamine for Melancholia
This study aims at investigating the special effectiveness of antidepressant effect of Fluvoxamine for endogenous depression. The investigators also aim to assess the effect of Fluvoxamine on the multimodal magnetic resonance imaging(MRI), blood cytokines, feces bacteria flora and neuropsychological performance in depression patients with melancholic features. The investigators further aim to identify the predictors of Fluvoxamine's antidepressant effeect using the above techniques.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Simultaneous FMRI and NIRS to Estimate Brain Cerebral Metabolism#888587
- Four Dimensions in Schizophrenia#916987
- Oral Uridine for Treatment of Bipolar Depression in Adolescents#836770
- IL-1β pathway-dependent regulation of glutamate receptor activity by gut microbiota in bipolar depression.#457738
- Latent Structure of Multi-level Assessments and Predictors of Outcomes in Psychiatric Disorders#852313
Record · ID 907421
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive